ORBIMED ADVISORS LLC 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-15 4:30 pm Unchanged |
2022-03-10 | 13D | Sierra Oncology, Inc. SRRA |
ORBIMED ADVISORS LLC | 3,044,753 12.200% |
0 (Unchanged) |
Filing |
| 2022-02-02 4:33 pm Unchanged |
2022-01-31 | 13D | Sierra Oncology, Inc. SRRA |
ORBIMED ADVISORS LLC | 3,044,753 15.300% |
0 (Unchanged) |
Filing |
| 2021-11-05 4:26 pm Purchase |
2021-11-05 | 13D | Sierra Oncology, Inc. SRRA |
ORBIMED ADVISORS LLC | 3,044,753 18.100% |
3,033,090 (+26006.64%) |
Filing |